Molecules Engineered Against Oncogenic Proteins and Cancer Discovery, Design,...

[Farid]

Molecules Engineered Against Oncogenic Proteins and Cancer | 391 | Corey, E. J.;Wu, Yong-Jin;
2023 | Wiley | 1394207085

Molecules Engineered Against Oncogenic Proteins and Cancer A comprehensive review of the latest molecular advances in cancer treatment Featuring 91 total small molecule kinase/KRAS inhibitors, 80 of which are FDA-approved, Molecules Engineered Against Oncogenic Proteins and Cancer documents the recent scientific advances that have transformed one of medicine's most challenging areas―cancer treatment. Most of these inhibitors specifically block oncogene-induced carcinogenic proteins with results that have dramatically advanced the treatment of cancer. In addition, the structural formulas of more than 100 kinase/KRAS inhibitors in clinical trials are presented. With a very well-known chemist as an author, Molecules Engineered Against Oncogenic Proteins and Cancer includes information Combining the most significant recent discoveries in a unique and useful way, Molecules Engineered Against Oncogenic Proteins and Cancer is an essential resource for researchers and students in bioscience, medicine, chemistry, and oncology as well as for those at industrial companies involved in therapeutic discovery.

Contents of Download:
Molecules Engineered Against Oncogenic Proteins and Cancer Discovery, Design, and Development.pdf (66.64 MB)

NitroFlare Link(s)

[To see links please register or login]

RapidGator Link(s)

[To see links please register or login]